Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells

Virology. 1993 Mar;193(1):303-12. doi: 10.1006/viro.1993.1126.

Abstract

Previously, we have shown that interferon (IFN)-alpha markedly inhibits human immunodeficiency virus type-1 (HIV-1) replication in the CEM-174 lymphocytic cell line during a single replication cycle. In the present study, we demonstrate that the IFN-mediated block of HIV-1 replication is at the level of HIV-1 provirus formation. Using polymerase chain reaction and a set of primers that detects complete or nearly complete proviral DNA, HIV-1 provirus could be found as early as 5 hr after infection in CEM-174 cells and peripheral blood lymphocytes. Pretreatment of cells with 500 U/ml IFN-alpha resulted in a significant reduction in the relative levels of HIV-1 proviral DNA. The levels of HIV-1 proviral DNA in IFN-alpha-treated cells were also reduced when primers detecting the early reverse-transcripts were used, indicating that IFN interferes with the initiation of HIV-1 reverse-transcription. The inhibition of provirus formation was also observed in vitro; addition of cytoplasmic extracts from IFN-treated CEM-174 cells, but not from the control cells, resulted in inhibition of both virion-associated and recombinant HIV-1 reverse transcriptase activity. These studies implicate that, when used therapeutically, IFN-alpha should limit the spread of HIV-1 infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Cell Line
  • HIV-1 / drug effects*
  • HIV-1 / isolation & purification
  • Humans
  • Interferon-alpha / pharmacology*
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Proviruses / drug effects*
  • Proviruses / isolation & purification
  • RNA, Viral / analysis
  • T-Lymphocytes / microbiology
  • Transcription, Genetic / drug effects*
  • Virus Replication / drug effects*

Substances

  • Interferon-alpha
  • RNA, Viral